In conclusion, these findings all support a potential oncogenic role of the SPHK1/S1P axis in lung diseases, and understanding its carcinogenic mechanism may bring new insights into the treatment of NSCLC or other diseases. This evidence concerns the gene SPHK1 and lung disorder.